French Innovative Leukemia Organisation

This study tested whether a newer, chemotherapy-free combination of two targeted drugs (venetoclax and ibrutinib) could be as good as or better than the standard chemotherapy-based treatment (FCR) for patients with intermediate-risk chronic lymphocytic leukemia (CLL). It involved…

This study tested a chemotherapy-free treatment approach for adults with previously untreated chronic lymphocytic leukemia (CLL), a type of blood cancer. All 135 participants received two targeted drugs (obinutuzumab and ibrutinib) for nine months. After this initial treatment, d…

This study looked back at the medical records of 152 adults with chronic lymphocytic leukemia (CLL) to understand what happens after two common types of oral medications stop working. The goal was to see what treatments doctors tried next and how patients responded, because there…